Zacks Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-36,222
Closed -$2.05M 607
2019
Q3
$2.05M Buy
+36,222
New +$2.05M 0.04% 253